GE HealthCare Technologies Inc.
Financials
Valuation Metrics
GE HealthCare Technologies Inc.'s Market Cap is $31.72B. At end of 2025 it was $37.43B. Ranked #452 of 3,111 in US market (top 15%), #135 of 1,445 on NASDAQ (top 9%), #29 of 206 in Health Care Equipment & Services (top 14%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $31.72B | US#452/3,111 Sec#29/206 |
| Revenue | $20.24B | US#322/3,111 Sec#23/206 |
| Net Income | $1.59B | US#385/3,111 Sec#16/206 |
| Total Assets | $37.25B | US#403/3,111 Sec#19/206 |
| Net Assets | $10.97B | US#392/3,111 Sec#22/206 |
| Employees | 54,000 | US#160/3,111 Sec#20/206 |
| Value | ||
| P/E | 19.92x | US#1,009/3,111 Sec#21/206 |
| P/B | 2.89x | US#1,625/3,111 Sec#92/206 |
| PEG | 1.11x | US#840/3,111 Sec#35/206 |
| P/S | 1.57x | US#1,006/3,111 Sec#69/206 |
| EV/EBITDA | 11.93x | US#1,034/3,111 Sec#36/206 |
| FCF Yield | 2.82% | US#1,789/3,111 Sec#107/206 |
| Profitability | ||
| ROE | 14.51% | US#906/3,111 Sec#43/206 |
| ROA | 4.27% | US#1,141/3,111 Sec#69/206 |
| Op. Margin | 12.70% | US#1,406/3,111 Sec#58/206 |
| Revenue Growth | 5.77% | US#1,676/3,111 Sec#123/206 |
| Earnings Growth | 17.90% | US#949/3,111 Sec#46/206 |
| Financial Health | ||
| Debt Ratio | 239.23% | US#1,957/3,111 Sec#167/206 |
| Total Debt | $10.09B | US#398/3,111 Sec#22/206 |
| FCF | $895M | US#618/3,111 Sec#39/206 |
| Cash | $2.10B | US#407/3,111 Sec#22/206 |
| Current Ratio | 1.02x | US#2,259/3,111 Sec#192/206 |
| Net Debt/EBITDA | 2.40x | US#1,466/3,111 Sec#90/206 |
| Dividend | ||
| Div. Yield | 0.15% | US#1,649/3,111 Sec#51/206 |
| Div. Growth | 16.25% | US#315/3,111 Sec#10/206 |
| Performance | ||
| 1Y Return | -0.09% | US#2,159/3,111 Sec#149/206 |
| 1M Return | 6.34% | US#908/3,111 Sec#78/206 |
| From 52W High | -22.29% | US#1,860/3,111 Sec#127/206 |
| 1Y MDD | -32.49% | US#1,546/3,111 Sec#70/206 |
| Trading | ||
| Volume | 4,104,862 shares | US#472/3,111 Sec#21/206 |
| Trading Value | $286M | US#384/3,111 Sec#28/206 |
| Per Share | ||
| EPS | $3.68 | US#842/3,111 Sec#50/206 |
| BPS | $22.73 | US#1,094/3,111 Sec#64/206 |
Company Info
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.